Department of Cardiology

Advancing cardiovascular research, clinical practice, prevention, diagnosis, and treatment of heart and vascular diseases.

Explore Published Articles Submit an Article
Department Overview

Aims and Scope

Cardiovascular health depends on the coordinated functioning of the heart, blood vessels, circulating blood and the regulatory systems that maintain tissue perfusion. Disturbances in these processes contribute to a wide spectrum of acute and chronic diseases, from coronary artery obstruction and rhythm abnormalities to heart failure and systemic vascular disorders. The Department of Cardiology of The Gazette of Medical Sciences (The GMS) provides a forum for scientific investigations into cardiovascular structure, function, disease mechanisms, prevention, diagnosis and treatment. Its scope embraces clinical cardiology, cardiovascular physiology, experimental research, translational medicine and interdisciplinary studies that advance understanding of cardiovascular health.

Clinical investigation is essential to improving the recognition and management of cardiovascular disease. The Department welcomes research addressing acute coronary syndromes, coronary artery disease, myocardial infarction, cardiac arrhythmias, cardiomyopathies, congenital heart disease, valvular disorders, hypertension, heart failure and diseases of the aorta and peripheral circulation. Studies involving thromboembolic complications, cardiac infections, inflammatory disorders, cerebrovascular conditions and cardiometabolic disease are also relevant. Clinical trials, observational investigations, case series and well-documented case reports may contribute to the evaluation of diagnostic approaches, treatment outcomes, complications and long-term cardiovascular prognosis.

Advances in cardiovascular medicine depend on understanding the biological mechanisms underlying cardiac and vascular dysfunction. Research into myocardial metabolism, electrophysiology, vascular biology, endothelial function, haemodynamics, atherosclerosis, thrombosis, cardiac remodelling, inflammation and oxidative stress falls within the Department's remit. Experimental investigations may examine cellular signalling, molecular pathways, genetic susceptibility, cardiac development, cardiovascular biomarkers and regenerative mechanisms. Contributions involving cardiovascular imaging, echocardiography, cardiac magnetic resonance, computed tomography, electrophysiological testing and haemodynamic assessment are encouraged where they improve physiological understanding or diagnostic precision.

Therapeutic innovation and cardiovascular prevention are equally important dimensions of the Department's coverage. Relevant investigations include interventional cardiology, coronary revascularization, structural heart interventions, cardiac surgery, catheter-based therapies, cardiac rhythm management, mechanical circulatory support and cardiovascular pharmacotherapy. Preventive cardiology encompasses lipid disorders, smoking, physical inactivity, nutrition, obesity, diabetes, hypertension and other modifiable risk factors. The Department also welcomes studies involving cardiovascular epidemiology, rehabilitation, digital health, artificial intelligence, remote monitoring and precision medicine, particularly where these approaches demonstrate meaningful implications for clinical decisions and patient outcomes.

Cardiovascular research increasingly requires collaboration among cardiologists, cardiac surgeons, internists, physiologists, pharmacologists, imaging specialists, biomedical engineers and public health researchers. The Department welcomes original research, clinical and experimental studies, systematic and narrative reviews, methodological investigations and appropriately documented clinical cases within the journal's applicable article categories. Submissions should clearly describe their research questions, methods, ethical considerations, statistical approaches and limitations. Claims regarding diagnostic accuracy, therapeutic benefit or novel biological mechanisms should be proportionate to the supporting evidence. Through independent editorial assessment and peer review, the Department seeks to contribute to reliable cardiovascular knowledge and its responsible application in clinical practice.

Areas of Interest

  • Acute Coronary Syndromes
  • Coronary Artery Disease
  • Myocardial Infarction
  • Cardiac Arrhythmias
  • Cardiac Electrophysiology
  • Cardiomyopathies
  • Cardiovascular Physiology
  • Cardiovascular Pathophysiology
  • Cardiovascular Regeneration
  • Congenital Heart Disease
  • Cardiometabolic Disease
  • Cardiovascular Biomarkers
  • Dyslipidaemias
  • Cardiovascular Epidemiology
  • Heart Failure
  • Hypertension
  • Cardiovascular Imaging
  • Echocardiography
  • Cardiac Magnetic Resonance Imaging
  • Cardiac Computed Tomography
  • Nuclear Cardiology
  • Haemodynamic Assessment
  • Cardiac Infections and Inflammation
  • Myocarditis and Pericardial Disease
  • Interventional Cardiology
  • Coronary Revascularization
  • Structural Heart Interventions
  • Cardiac Surgery
  • Cardiac Rhythm Management
  • Cardiac Implantable Electronic Devices
  • Cardiovascular Pharmacotherapy
  • Antithrombotic Therapy
  • Preventive Cardiology
  • Cardiovascular Risk Assessment
  • Cardiac Rehabilitation
  • Stroke and Cardiovascular Disease
  • Cardiovascular Thrombosis
  • Valvular Heart Disease
  • Aortic Diseases
  • Aortic and Peripheral Aneurysms
  • Atherosclerosis
  • Carotid Artery Disease
  • Peripheral Arterial Disease
  • Venous Thromboembolism
  • Vascular Biology
  • Endothelial Dysfunction
  • Cardiac Remodelling
  • Myocardial Metabolism
  • Cardiovascular Genetics
  • Molecular Cardiology
  • Inflammation and Oxidative Stress
  • Heart Transplantation
  • Mechanical Circulatory Support
  • Pulmonary Hypertension
  • Adult Congenital Cardiology
  • Paediatric Cardiology
  • Geriatric Cardiology
  • Cardio-Oncology
  • Cardio-Renal Interactions
  • Cardiovascular Disease in Pregnancy
  • Sports Cardiology
  • Digital Cardiology and Remote Monitoring
  • Artificial Intelligence in Cardiology
  • Precision Cardiovascular Medicine
  • Clinical Trials in Cardiology
  • Cardiovascular Outcomes Research
Research & Reviews

Published Articles

Case Report

Post-infarctual left ventricular apical thrombosis successfully treated with low-dose apixaban: A case report

The recommended treatment for ventricular thrombosis is based on vitamin K antagonists use for at least 3 months. Till now there are not completed trials that allow use of direct oral anticoagulants for this specific complication in neither chronic nor acute settings. We report the case of a subacute left ventricular apical thrombosis complicating a myocardial infarction in a 78-years-old patient effectively treated with low-dose apixaban (2.5 mg twice daily) associated with dual antithrombotic therapy.

DOI: https://www.doi.org/10.46766/thegms.cardio.20042201
View / Download Article ↗
Contribute to Cardiovascular Research

Submit Your Research

Please direct any enquiry or submit papers to: info@thegms.co

Manuscript Submission Form Article Preparation Guidelines Article Type Specifications Editorial Policies Costs and Waivers Contact Us